Benefit/risk analysis of aggressive mammographic screening

Area of Science:

• Radiology
• Oncology
• Public Health

Background:

• Mammography is a key tool for breast cancer screening.
• Assessing the benefit-risk ratio is crucial for optimizing screening protocols.
• Previous studies have established the efficacy of mammography in reducing breast cancer mortality.

Purpose of the Study:

• To develop a model for estimating the benefit-risk ratio of mammography screening in asymptomatic women.
• To quantify the number of breast cancer deaths averted by mammography screening.
• To provide data for informed decision-making regarding mammography screening programs.

Main Methods:

• Analysis of screening data from 20,000 women.
• Development of a model to estimate the benefit-risk ratio.
• Calculation of breast cancer deaths averted based on an annual average midbreast absorbed dose of 1 rad per year.

Main Results:

• The "worst-case" benefit/risk ratio for five annual mammographic examinations in women aged 35-49 is estimated at 3.4 +/- 1.1 to 1.
• The "most probable" benefit/risk ratio is estimated at 8.0 +/- 3.1 to 1.
• These ratios indicate a substantial benefit in terms of averted breast cancer deaths.

Conclusions:

• Mammography screening offers a favorable benefit-risk ratio for asymptomatic women.
• The model provides a quantitative estimate of the benefits of mammography in averting breast cancer deaths.
• The findings support the continued use and optimization of mammography screening programs.